Milkman 2.0 - A new paradigm for medtech commercial (pdf)
As a result of their original global medtech commercial benchmarking study in 2012, The Boston Consulting Group will this year elaborate if the industry is "still deploying milkmen in a megastore World". BCG argued that the industry had significant work to do in improving the efficiency of the commercial model while strengthening capabilities across the full spectrum of commercial excellence.
Based on the just completed 2nd edition of the "Milkman Study", Goetz Gerecke will share, hot off the press, to what extent industry has been able to move the needle in fixing the medtech commercial model.
Goetz will present a vision on how to ensure profitable growth in an environment increasingly shaped by value-based healthcare, digital disruption and low-cost competition.